Eldelumab Completed Phase 2 Trials for Crohn's Disease (CD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01466374Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease